Items Tagged ‘Genetics’

May 20, 2019

Calquence Improves Survival in Relapsed Chronic Lymphocytic Leukemia

By

An interim analyses of the phase 3 “ASCEND” clinical trial evaluating single-agent Calquence (acalabrutinib) compared to Rituxan (rituximab) plus idelasib or bendamustine in recurrent chronic lymphocytic leukemia (CLL) is closed early due to favorable results. (1) About chronic lymphocytic leukemia CLL is the most common type of leukemia in adults. (2) with an average age […]

View full entry

Tags: Chronic Lymphoblastic Leukemia, Genetics, germline mutations, Hereditary Caner Test, hereditary risk, Leukemia, myRisk, News, Prostate Cancer


February 14, 2018

Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation

By

Myriad Genetics a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.  The key finding is that more than 12 percent of men with prostate cancer had an inherited (i.e. […]

View full entry

Tags: Genetics, germline mutations, Hereditary Caner Test, hereditary risk, myRisk, News, Prostate Cancer